Literature DB >> 12388253

Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase.

Alyson J Prorock1, Ali Hafezi-Moghadam, Victor E Laubach, James K Liao, Klaus Ley.   

Abstract

Estrogen increases nitric oxide (NO) production by inducing the activity of endothelial NO synthase (eNOS) (Simoncini et al. Nature 407: 538, 2000). Ischemia (30 min) and reperfusion (I/R) increased the number of adherent leukocytes and decreased their rolling velocities in mouse cremaster muscle venules with a strong dependence on wall shear rate. Minimum rolling velocity at approximately 5 min after the onset of reperfusion was accompanied by increased P-selectin expression. This preceded the peak in leukocyte adhesion (at 10-15 min). In untreated wild-type mice, I/R caused a decrease of leukocyte rolling velocity from 37 to 26 microm/s and a 2.0-fold increase in leukocyte adhesion. Both were completely abolished by 0.25 mg ip estrogen 1 h before surgery. In eNOS(-/-) mice, the decrease of leukocyte rolling velocity and increase in adhesion were similar but were only marginally improved by estrogen. We conclude that the protective effect of estrogen, as measured by leukocyte rolling and adhesion, is significantly reduced in eNOS(-/-) mice, suggesting that induction of eNOS activity is the major mechanism of vasoprotection by estrogen in this model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388253     DOI: 10.1152/ajpheart.00957.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.

Authors:  Amrita Ahluwalia; Paul Foster; Ramona S Scotland; Peter G McLean; Anthony Mathur; Mauro Perretti; Salvador Moncada; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-23       Impact factor: 11.205

Review 2.  Can oestrogen influence skeletal muscle damage, inflammation, and repair?

Authors:  P M Tiidus
Journal:  Br J Sports Med       Date:  2005-05       Impact factor: 13.800

3.  Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.

Authors:  M Ahsan Siraj; Dhanwantee Mundil; Sanja Beca; Abdul Momen; Eric A Shikatani; Talat Afroze; Xuetao Sun; Ying Liu; Siavash Ghaffari; Warren Lee; Michael B Wheeler; Gordon Keller; Peter Backx; Mansoor Husain
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 4.  The influence of estrogen on skeletal muscle: sex matters.

Authors:  Deborah L Enns; Peter M Tiidus
Journal:  Sports Med       Date:  2010-01-01       Impact factor: 11.136

5.  Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃.

Authors:  Elisabeth I Schmitz; Henrik Potteck; Melanie Schüppel; Marianti Manggau; Elly Wahydin; Burkhard Kleuser
Journal:  Mol Cell Biochem       Date:  2012-08-17       Impact factor: 3.396

6.  Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury.

Authors:  Helena Block; Jan M Herter; Jan Rossaint; Anika Stadtmann; Stefanie Kliche; Clifford A Lowell; Alexander Zarbock
Journal:  J Exp Med       Date:  2012-01-30       Impact factor: 14.307

7.  Oxidant/antioxidant state in tissue of prymary and recurrent pterygium.

Authors:  Alexandre Kormanovski; Fidelina Parra; Adriana Jarillo-Luna; Eleazar Lara-Padilla; Judith Pacheco-Yépez; Rafael Campos-Rodriguez
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

8.  Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.

Authors:  Ryoichi Arita; Yasuaki Hata; Shintaro Nakao; Takeshi Kita; Muneki Miura; Shuhei Kawahara; Souska Zandi; Lama Almulki; Faryan Tayyari; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.